Literature DB >> 27890346

The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy.

F R Bartlett1, E M Donovan2, H A McNair3, L A Corsini3, R M Colgan2, P M Evans4, L Maynard5, C Griffin5, J S Haviland6, J R Yarnold7, A M Kirby8.   

Abstract

AIMS: To evaluate the feasibility and heart-sparing ability of the voluntary breath-hold (VBH) technique in a multicentre setting.
MATERIALS AND METHODS: Patients were recruited from 10 UK centres. Following surgery for early left breast cancer, patients with any heart inside the 50% isodose from a standard free-breathing tangential field treatment plan underwent a second planning computed tomography (CT) scan using the VBH technique. A separate treatment plan was prepared on the VBH CT scan and used for treatment. The mean heart, left anterior descending coronary artery (LAD) and lung doses were calculated. Daily electronic portal imaging (EPI) was carried out and scanning/treatment times were recorded. The primary end point was the percentage of patients achieving a reduction in mean heart dose with VBH. Population systematic (Σ) and random errors (σ) were estimated. Within-patient comparisons between techniques used Wilcoxon signed-rank tests.
RESULTS: In total, 101 patients were recruited during 2014. Primary end point data were available for 93 patients, 88 (95%) of whom achieved a reduction in mean heart dose with VBH. Mean cardiac doses (Gy) for free-breathing and VBH techniques, respectively, were: heart 1.8 and 1.1, LAD 12.1 and 5.4, maximum LAD 35.4 and 24.1 (all P<0.001). Population EPI-based displacement data showed Σ =+1.3-1.9 mm and σ=1.4-1.8 mm. Median CT and treatment session times were 21 and 22 min, respectively.
CONCLUSIONS: The VBH technique is confirmed as effective in sparing heart tissue and is feasible in a multicentre setting.
Copyright © 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; breath-hold; cardiac dose; heart-sparing breast radiotherapy; radiotherapy

Mesh:

Year:  2016        PMID: 27890346     DOI: 10.1016/j.clon.2016.11.005

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  17 in total

Review 1.  Effects of Radiotherapy in Coronary Artery Disease.

Authors:  Rose Mary Ferreira Lisboa da Silva
Journal:  Curr Atheroscler Rep       Date:  2019-11-19       Impact factor: 5.113

Review 2.  Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC).

Authors:  Long-Sheng Lu; Yen-Wen Wu; Joseph Tung-Chieh Chang; Wei-Ting Chang; Ting-Hsing Chao; Helen Hai-Wen Chen; Yu-Jen Chen; Kai-Hung Cheng; Wen-Lin Hsu; Chung-Lieh Hung; Sung-Hsin Kuo; Ji-An Liang; Hung-Ju Lin; Ping-Yen Liu; Wen-Shan Liu; Yen-Wen Liu; Pei-Wei Shueng; Chao-Yung Wang; Charles Jia-Yin Hou; Jeng-Fong Chiou
Journal:  Acta Cardiol Sin       Date:  2022-01       Impact factor: 2.672

3.  Whole breast and regional nodal irradiation in prone versus supine position in left sided breast cancer.

Authors:  Pieter Deseyne; Bruno Speleers; Wilfried De Neve; Bert Boute; Leen Paelinck; Tom Van Hoof; Joris Van de Velde; Annick Van Greveling; Chris Monten; Giselle Post; Herman Depypere; Liv Veldeman
Journal:  Radiat Oncol       Date:  2017-05-26       Impact factor: 3.481

4.  Monitoring deep inspiration breath hold for left-sided localized breast cancer radiotherapy with an in-house developed laser distance meter system.

Authors:  Christer A Jensen; Tatiana Abramova; Jomar Frengen; Jo-Åsmund Lund
Journal:  J Appl Clin Med Phys       Date:  2017-07-29       Impact factor: 2.102

5.  Dosimetric evaluation of deep inspiration breath hold for left-sided breast cancer: analysis of patient-specific parameters related to heart dose reduction.

Authors:  Ryohei Yamauchi; Norifumi Mizuno; Tomoko Itazawa; Hidetoshi Saitoh; Jiro Kawamori
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724

Review 6.  Dosimetric evaluation and systematic review of radiation therapy techniques for early stage node-negative breast cancer treatment.

Authors:  Tabitha Y Chan; Johann I Tang; Poh Wee Tan; Neill Roberts
Journal:  Cancer Manag Res       Date:  2018-10-23       Impact factor: 3.989

7.  The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors.

Authors:  Anna-Karin Wennstig; Hans Garmo; Ulf Isacsson; Giovanna Gagliardi; Niina Rintelä; Bo Lagerqvist; Lars Holmberg; Carl Blomqvist; Malin Sund; Greger Nilsson
Journal:  Radiat Oncol       Date:  2019-03-07       Impact factor: 3.481

Review 8.  Recent advances in radiotherapy of breast cancer.

Authors:  Jan Haussmann; Stefanie Corradini; Carolin Nestle-Kraemling; Edwin Bölke; Freddy Joel Djiepmo Njanang; Bálint Tamaskovics; Klaus Orth; Eugen Ruckhaeberle; Tanja Fehm; Svjetlana Mohrmann; Ioannis Simiantonakis; Wilfried Budach; Christiane Matuschek
Journal:  Radiat Oncol       Date:  2020-03-30       Impact factor: 3.481

9.  Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.

Authors:  Adrian Murray Brunt; Joanne S Haviland; Duncan A Wheatley; Mark A Sydenham; Abdulla Alhasso; David J Bloomfield; Charlie Chan; Mark Churn; Susan Cleator; Charlotte E Coles; Andrew Goodman; Adrian Harnett; Penelope Hopwood; Anna M Kirby; Cliona C Kirwan; Carolyn Morris; Zohal Nabi; Elinor Sawyer; Navita Somaiah; Liba Stones; Isabel Syndikus; Judith M Bliss; John R Yarnold
Journal:  Lancet       Date:  2020-04-28       Impact factor: 202.731

10.  Evaluation of the heart and lung dosimetric parameters in deep inspiration breath hold using 3D Slicer.

Authors:  Azam Eskandari; Shahrokh Nasseri; Hamid Gholamhosseinian; Sare Hosseini; Mohammad Javad Keikhai Farzaneh; Alireza Keramati; Maryam Naji; Atefeh Rostami; Mehdi Momennezhad
Journal:  Radiat Oncol J       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.